Literature DB >> 26803377

A systematic review of interventions to reduce hospitalisation in Parkinson's disease.

S Muzerengi1, C Herd2, C Rick2, C E Clarke3.   

Abstract

UNLABELLED: The neurodegenerative process in Parkinson's disease (PD) results in a relentless progression of motor and non-motor symptoms. Affected individuals are frequently hospitalised for complications of the disease including falls, fractures, infections, and neuropsychiatric symptoms. When admitted to hospital, inpatient care is often suboptimal as it focusses on the primary cause of admission, and is associated with poor patient outcomes and significant healthcare costs. AIM: To review existing literature for evidence-based interventions aimed at reducing hospital admissions in PD.
METHODS: Electronic literature search in EMBASE, MEDLINE and CINAHL databases for studies evaluating interventions to reduce hospital admissions in PD. We included publications with full abstracts, published in the English language and addressing interventions to reduce hospital admissions in PD.
RESULTS: To date there are no randomised controlled trials addressing the topic. We identified nine relevant retrospective studies. Results from these studies suggest an association between frequent neurologist consultations, open access clinics, and medication compliance with a reduction in PD hospital admissions and emergency room visits.
CONCLUSION: This systematic review highlights the lack of robust evidence for measures aimed at reducing hospital admissions in people with PD. Future prospective studies are required to evaluate the effectiveness of proposed interventions.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hospitalisation; Interventions; Parkinson's disease; Randomised controlled trial

Mesh:

Year:  2016        PMID: 26803377     DOI: 10.1016/j.parkreldis.2016.01.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Parkinson's Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing Plan.

Authors:  Michelle H S Tosin; Christopher G Goetz; Dharah P C F Bispo; Henrique B Ferraz; Marco Antonio A Leite; Deborah A Hall; Glenn T Stebbins; Beatriz Guitton R B Oliveira
Journal:  Front Aging Neurosci       Date:  2022-05-13       Impact factor: 5.702

2.  Hospitalization and rehospitalization in Parkinson disease patients: Data from the National Parkinson Foundation Centers of Excellence.

Authors:  Leili Shahgholi; Sol De Jesus; Samuel S Wu; Qinglin Pei; Anhar Hassan; Melissa J Armstrong; Daniel Martinez-Ramirez; Peter Schmidt; Michael S Okun
Journal:  PLoS One       Date:  2017-07-06       Impact factor: 3.240

3.  Multicentre, randomised controlled trial of PDSAFE, a physiotherapist-delivered fall prevention programme for people with Parkinson's.

Authors:  Kim Chivers Seymour; Ruth Pickering; Lynn Rochester; Helen C Roberts; Claire Ballinger; Sophia Hulbert; Dorit Kunkel; Ioana R Marian; Carolyn Fitton; Emma McIntosh; Victoria A Goodwin; Alice Nieuwboer; Sarah E Lamb; Ann Ashburn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-04-03       Impact factor: 10.154

4.  Sex-Specific Patient Journeys in Early Parkinson's Disease in the Netherlands.

Authors:  Floris Pieter Vlaanderen; Yvonne de Man; Jesse H Krijthe; Marit A C Tanke; A S Groenewoud; Patrick P T Jeurissen; Sabine Oertelt-Prigione; Marten Munneke; Bastiaan R Bloem; Marjan J Meinders
Journal:  Front Neurol       Date:  2019-07-30       Impact factor: 4.003

5.  Interventions to minimize complications in hospitalized patients with Parkinson disease.

Authors:  Sana Aslam; Edith Simpson; Matthew Baugh; Holly Shill
Journal:  Neurol Clin Pract       Date:  2020-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.